{
  "zip": "104-0044",
  "sector": "",
  "fullTimeEmployees": 74,
  "longBusinessSummary": "SanBio Company Limited develops, produces, and sells regenerative cell medicines for central nervous system. The company develops SB623, a therapeutic product that is in Phase II clinical trial for chronic motor deficit from traumatic brain injury. Its research pipeline products also comprise SB623 for strokes, age-related macular degeneration, retinitis pigments, spinal cord injury, Parkinson's disease, Alzheimer's disease, and others; SB618, a therapeutic agent for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease. SanBio Company Limited has an agreement with National University Corporation Asahikawa Medical University for the development of SB623 for the indication of retinal disease; Juntendo University to joint research into the production of pancreatic beta cells, as well as Ocumension (Hong Kong) Limited for the research, development, and commercialization of stem cell therapies for ophthalmic diseases; and Nippon Medical School to joint research into investigation of the efficacy of SB623 in the treatment of traumatic brain injury at subacute phase. The company was founded in 2001 and is headquartered in Tokyo, Japan.",
  "city": "Tokyo",
  "phone": "81 3 6264 3481",
  "country": "Japan",
  "companyOfficers": [],
  "website": "http://www.sanbio.jp",
  "maxAge": 1,
  "address1": "St. Luke Tower",
  "industry": "",
  "address2": "28th Floor 8-1 Akashi-cho Chuo-ku",
  "previousClose": 14.95,
  "regularMarketOpen": 14.95,
  "twoHundredDayAverage": 16.556522,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 14.95,
  "navPrice": null,
  "averageDailyVolume10Day": 37,
  "totalAssets": null,
  "regularMarketPreviousClose": 14.95,
  "fiftyDayAverage": 17.751514,
  "trailingAnnualDividendRate": null,
  "open": 14.95,
  "averageVolume10days": 37,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.131767,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 14.95,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 4,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 663303104,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 81,
  "priceToSalesTrailing12Months": null,
  "dayLow": 14.95,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 4,
  "fiftyTwoWeekHigh": 36.9,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 11.3,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 14.95,
  "exchange": "PNK",
  "shortName": "SANBIO COMPANY LIMITED",
  "longName": "SanBio Company Limited",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "SNBIF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_273682705",
  "uuid": "19f850f4-963e-3216-93b1-7a9da884775c",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 49699900,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 1.861,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1580428800,
  "heldPercentInstitutions": 0.04107,
  "netIncomeToCommon": null,
  "trailingEps": -0.446,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 8.033316,
  "heldPercentInsiders": 0.45319998,
  "nextFiscalYearEnd": 1643587200,
  "mostRecentQuarter": 1604102400,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 28626919,
  "enterpriseValue": 774190400,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 14.95,
  "logo_url": "https://logo.clearbit.com/sanbio.jp"
}